Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolism

Neurochemistry International

Volumn 49, Issue 5, 2006, Pages 548-556

  Ke, Zun Ji ^a,b   Bowen, William M ^b   Gibson, Gary E ^b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Inflammation; Microglia; Neurodegeneration; Thiamine deficiency

Indexed keywords

CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIAMINE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BRAIN REGION; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE DELETION; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; KNOCKOUT MOUSE; MALE; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECIES COMPARISON; T LYMPHOCYTE ACTIVATION; THIAMINE DEFICIENCY;

ANIMALS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NADPH OXIDASE; OXIDATIVE STRESS; T-LYMPHOCYTES;

EID: 33746878868     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.04.011     Document Type: Article

References (64)

1. Armitage R.J., Fanslow W.C., Strockbine L., Sato T.A., Clifford K.N., Macduff B.M., Anderson D.M., Gimpel S.D., Davis-Smith T., and Maliszewski C.R. Molecular and biological characterization of a murine ligand for CD40. Nature 357 (1992) 80-82
2. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
3. Ballok D.A., Millward J.M., and Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. 964 (2003) 200-210
4. Benveniste E.N., Nguyen V.T., and O'Keefe G.M. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39 (2001) 381-391
5. Benveniste E.N., Nguyen V.T., and Wesemann D.R. Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav. Immun. 18 (2004) 7-12
6. Phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line. Blood 87 (1996) 2005-2010
7. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to Interferon-gamma. Annu. Rev. Immunol. 15 (1997) 749-795
8. Buttini M., Westland C.E., Masliah E., Yafeh A.M., Wyss-Coray T., and Mucke L. Novel role of human CD4 molecule identified in neurodegeneration. Nat. Med. 4 (1998) 441-446
9. Calingasan N.Y., Chun W.J., Park L.C., Uchida K., and Gibson G.E. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency. J. Neuropathol. Exp. Neurol. 58 (1999) 946-958
10. Calingasan N.Y., and Gibson G.E. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann. N. Y. Acad. Sci. 903 (2000) 353-356
11. Calingasan N.Y., Erdely H.A., and Altar C.A. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury. Neurobiol. Aging 23 (2002) 31-39
12. Calingasan N.Y., Huang P.L., Chun H.S., Fabian A., and Gibson G.E. Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism. J. Neuropathol. Exp. Neurol. 59 (2000) 207-217
13. Chen Z., Duan R.S., Q H.C., Wu Q., Mix E., Winblad B., Ljunggren H.G., and Zhu J. IL-12p35 deficiency alleviates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice. Neurobiol. Dis. 17 (2004) 171-178
14. Chen Z., Yu S., Concha H.Q., Zhu Y., Mix E., Winblad B., Ljunggren H.G., and Zhu J. Kainic acid-induced excitotoxic hippocampal neurodegeneration in C57BL/6 mice: B cell and T cell subsets may contribute differently to the pathogenesis. Brain Behav. Immun. 18 (2004) 175-185
15. Engelhardt J.I., Tajti J., and Appel S.H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50 (1993) 30-36
16. Fanslow W.C., Anderson D.M., Grabstein K.H., Clark E.A., Cosman D., and Armitage R.J. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149 (1992) 655-660
17. Franklin K.B.J., and Paxinos G. The mouse brain in Stereotaxic coordinates. (1997), Academic Press, San Diego
18. Fung-Leung W.P., Schilham M.W., Rahemtulla A., Kundig T.M., Vollenweider M., Potter J., van Ewijk W., and Mak T.W. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65 (1991) 443-449
19. Gao H.M., Liu B., and Hong J.S. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 23 (2003) 6181-6187
20. Gao H.M., Liu B., Zhang W., and Hong J.S. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J. 17 (2003) 1954-1956
21. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., and Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2499-2504
22. Gibson G.E., Park L.C., Zhang H., Sorbi S., and Calingasan N.Y. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. Ann. N. Y. Acad. Sci. 893 (1999) 79-94
23. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., and Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20 14 (2000) 5283-5291
24. Hickey W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1 (1991) 97-105
25. Howard L.M., Dal Canto M.C., and Miller S.D. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses. J. Neuroimmunol. 129 (2002) 58-65
26. Itagaki S., McGeer P.L., and Akiyama H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci. Lett. 91 (1988) 259-264
27. Jin Y., Lundkvist G., Dons L., Kristensson K., and Rottenberg M.E. Interferon-gamma mediates neuronal killing of intracellular bacteria. Scand. J. Immunol. 60 (2004) 437-448
28. Kawamata T., Akiyama H., Yamada T., and McGeer P.L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140 (1992) 691-707
29. Ke Z.J., Calingasan N.Y., Degiorgio L.A., Volpe B.T., and Gibson G.E. CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. Neurochem. Int. 47 (2005) 204-215
30. Ke Z.J., Calingasan N.Y., Karuppagounder S.S., Degiorgio L.A., Volpe B.T., and Gibson G.E. CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. J. Neuroimmunol. 164 (2005) 85-92
31. Ke Z.J., DeGiorgio L.A., Volpe B.T., and Gibson G.E. Reversal of thiamine deficiency-induced neurodegeneration. J. Neuropathol. Exp. Neurol. 62 (2003) 195-207
32. Ke Z.J., and Gibson G.E. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism. Neurochem. Int. 45 (2004) 361-369
33. Phox distributions in rat brain. Brain Res. 1040 (2005) 178-186
34. Koustova E., Sei Y., McCarty T., Espey M.G., Ming R., Morse III H.C., and Basile A.S. Accelerated development of neurochemical and behavioral deficits in LP-BM5 infected mice with targeted deletions of the IFN-gamma gene. J. Neuroimmunol. 108 (2000) 112-121
35. Krause K.H., and Clark R.A. Geneva biology of ageing workshop 2000: phagocytes, inflammation, and ageing. Exp. Gerontol. 36 (2001) 373-381
36. Larbi A., Dupuis G., Douziech N., Khalil A., and Fulop Jr. T. Low-grade inflammation with aging has consequences for T-lymphocyte signaling. Ann. N. Y. Acad. Sci. 1030 (2004) 125-133
37. Li M., Pisalyaput K., Galvan M., and Tenner A.J. Macrophage colony stimulatory factor and Interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity. J. Neurochem. 91 (2004) 623-633
38. Lin W., Kemper A., McCarthy K.D., Pytel P., Wang J.P., Campbell I.L., Utset M.F., and Popko B. Interferon-gamma induced medulloblastoma in the developing cerebellum. J. Neurosci. 24 (2004) 10074-10083
39. McGeer P.L., and McGeer E.G. Inflammation and the degenerative diseases of aging. Ann. N. Y. Acad. Sci. 1035 (2004) 104-116
40. Monsonego A., Zota V., Karni A., Krieger J.I., Bar-Or A., Bitan G., Budson A.E., Sperling R., Selkoe D.J., and Weiner H.L. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 112 (2003) 415-422
41. Mullen R.J., Buck C.R., and Smith A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development 116 (1992) 201-211
42. Olsson T., Piehl F., Swanberg M., and Lidman O. Genetic dissection of neurodegeneration and CNS inflammation. J. Neurol. Sci. 233 (2005) 99-108
43. Orr C.F., Rowe D.B., and Halliday G.M. An inflammatory review of Parkinson's disease. Prog. Neurobiol. 68 (2002) 325-340
44. Park L., Anrather J., Zhou P., Frys K., Pitstick R., Younkin S., Carlson G.A., and Iadecola C. NADPH oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J. Neurosci. 25 (2005) 1769-1777
45. Park L., Anrather J., Zhou P., Frys K., Wang G., and Iadecola C. Exogenous NADPH increases cerebral blood flow through NADPH oxidase-dependent and -independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1860-1865
46. Patel M., Li Q.Y., Chang L.Y., Crapo J., and Liang L.P. Activation of NADPH oxidase and extracellular superoxide production in seizure-induced hippocampal damage. J. Neurochem. 92 (2005) 123-131
47. Pollock J.D., Williams D.A., Gifford M.A., Li L.L., Du X., Fisherman J., Orkin S.H., Doerschuk C.M., and Dinauer M.C. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9 (1995) 202-209
48. Qin L., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., Liu B., and Hong J.S. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279 (2004) 1415-1421
49. Raivich G., Bohatschek M., Werner A., Jones L.L., Galiano M., Kloss C.U., Zhu X.Z., Pfeffer K., and Liu Z.Q. Lymphocyte infiltration in the injured brain: role of proinflammatory cytokines. J. Neurosci. Res. 72 (2003) 726-733
50. Raivich G., Jones L.L., Kloss C.U., Werner A., Neumann H., and Kreutzberg G.W. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J. Neurosci. 18 (1998) 5804-5816
51. Saji M., Blau A.D., and Volpe B.T. Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus. Exp. Neurol. 141 (1996) 120-129
52. Sattentau Q.J., and Weiss R.A. The CD4 antigen: physiological ligand and HIV receptor. Cell 52 (1988) 631-633
53. + or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav. Immun. 17 5 (2003) 393-402
54. Serrano F., Kolluri N.S., Wientjes F.B., Card J.P., and Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Res. 988 (2003) 193-198
55. Suzukawa K., Miura K., Mitsushita J., Resau J., Hirose K., Crystal R., and Kamata T. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J. Biol. Chem. 275 (2000) 13175-13178
56. Tan J., Town T., and Mullan M. CD40-CD40L interaction in Alzheimer's disease. Curr. Opin. Pharmacol. 2 (2002) 445-451
57. Tejada-Simon M.V., Serrano F., Villasana L.E., Kanterewicz B.I., Wu G.Y., Quinn M.T., and Klann E. Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Mol. Cell Neurosci. 29 (2005) 97-106
58. Todd K.G., and Butterworth R.F. Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia 25 (1999) 190-198
59. Togo T., Akiyama H., Iseki E., Kondo H., Ikeda K., Kato M., Oda T., Tsuchiya K., and Kosaka K. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124 (2002) 83-92
60. Town T., Tan J., and Mullan M. CD40 signaling and Alzheimer's disease pathogenesis. Neurochem. Int. 39 (2001) 371-380
61. Wekerle H. T-cell autoimmunity in the central nervous system. Intervirology 35 (1993) 95-100
62. Wheeler R.D., and Owens T. The changing face of cytokines in the brain: perspectives from EAE. Curr. Pharm. Des. 11 8 (2005) 1031-1037
63. Zhang W., Wang T., Qin L., Gao H.M., Wilson B., Ali S.F., Zhang W., Hong J.S., and Liu B. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 18 (2004) 589-591
64. Zhu Y., Bao L., Zhu S., Chen Z., van der Meide P., Nennesmo I., Winblad B., Ljunggren H.G., and Zhu J. CD4 and CD8 T cells, but not B cells, are critical to the control of murine experimental autoimmune neuritis. Exp. Neurol. 177 (2002) 314-320